Atlas Trials

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Clinical trial NCT02047019 · WITHDRAWN

Trial details

NCT number
NCT02047019
Sponsor
Bayer
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2017-12-01
Primary completion
2019-12-08
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.